Anti-chlamydial activity of vaginal fluids: new evidence from an in vitro model

Front Cell Infect Microbiol. 2024 Jun 7:14:1403782. doi: 10.3389/fcimb.2024.1403782. eCollection 2024.

Abstract

Introduction: We assessed the in vitro anti-chlamydial activity of fresh vaginal secretions, deciphering the microbial and metabolic components able to counteract Chlamydia trachomatis viability.

Methods: Forty vaginal samples were collected from a group of reproductive-aged women and their anti-chlamydial activity was evaluated by inhibition experiments. Each sample underwent 16S rRNA metabarcoding sequencing to determine the bacterial composition, as well as 1H-NMR spectroscopy to detect and quantify the presence of vaginal metabolites.

Results: Samples characterized by a high anti-chlamydial activity were enriched in Lactobacillus, especially Lactobacillus crispatus and Lactobacillus iners, while not-active samples exhibited a significant reduction of lactobacilli, along with higher relative abundances of Streptococcus and Olegusella. Lactobacillus gasseri showed an opposite behavior compared to L. crispatus, being more prevalent in not-active vaginal samples. Higher concentrations of several amino acids (i.e., isoleucine, leucine, and aspartate; positively correlated to the abundance of L. crispatus and L. jensenii) lactate, and 4-aminobutyrate were the most significant metabolic fingerprints of highly active samples. Acetate and formate concentrations, on the other hand, were related to the abundances of a group of anaerobic opportunistic bacteria (including Prevotella, Dialister, Olegusella, Peptostreptococcus, Peptoniphilus, Finegoldia and Anaerococcus). Finally, glucose, correlated to Streptococcus, Lachnospira and Alloscardovia genera, emerged as a key molecule of the vaginal environment: indeed, the anti-chlamydial effect of vaginal fluids decreased as glucose concentrations increased.

Discussion: These findings could pave the way for novel strategies in the prevention and treatment of chlamydial urogenital infections, such as lactobacilli probiotic formulations or lactobacilli-derived postbiotics.

Keywords: Chlamydia trachomatis; lactobacilli; metabolome; vaginal microbiome; women’s health.

MeSH terms

  • Adult
  • Chlamydia Infections / microbiology
  • Chlamydia trachomatis* / isolation & purification
  • Female
  • Humans
  • Lactobacillus crispatus / isolation & purification
  • Lactobacillus* / genetics
  • Lactobacillus* / isolation & purification
  • Lactobacillus* / metabolism
  • RNA, Ribosomal, 16S* / genetics
  • Streptococcus / isolation & purification
  • Vagina* / microbiology
  • Young Adult

Substances

  • RNA, Ribosomal, 16S

Supplementary concepts

  • Lactobacillus iners

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.